Urachal adenocarcinoma with cervical invasion misdiagnosed as primary cervical adenocarcinoma: a case report and literature review

Yiran Wang, Maomao Li, Kaixuan Yang, Qingli Li, Ping WangFrontiers in Oncology 2024 · DOI

TL;DR

This paper presents a rare case of urachal adenocarcinoma (UrAC) that was initially misdiagnosed as cervical cancer for 2.5 years. The case highlights the critical importance of accurate histopathological examination and comprehensive analysis in diagnosing this rare malignancy, especially when it presents with unusual invasion patterns. The authors also suggest anterior pelvic exenteration as a potentially effective treatment for local recurrence.

What Problem Does This Paper Address?

Urachal carcinoma (UrC) is a rare malignancy arising from remnants of the urachus, a fetal structure connecting the bladder to the umbilicus. It accounts for less than 1% of all bladder cancers, with adenocarcinoma being the most common subtype. UrC often presents at advanced stages due to a lack of specific early symptoms, leading to a poor prognosis. A significant challenge in managing UrC is its accurate and timely diagnosis, as it can mimic other cancers, particularly those of the urinary tract and gastrointestinal system. This paper addresses the diagnostic difficulty of UrC, specifically when it presents with unusual invasion patterns, such as cervical invasion, leading to misdiagnosis as a primary gynecological malignancy.

Methods

This paper is primarily a case report and literature review. The authors detail a specific patient's journey, including:

  • Clinical Presentation and Imaging: The patient presented with a bladder mass detected via MRI, initially suspected as a recurrence of prior cervical adenocarcinoma. Further imaging (PET-CT) suggested involvement of the cervix and bladder.
  • Histopathological Examination: Biopsies were crucial. Initial biopsies from the cervical and vaginal regions were reassessed. Subsequent biopsies from the posterior urethral wall and later from the rectal metastasis were performed.
  • Immunohistochemistry (IHC): IHC staining was extensively used on tumor samples to identify specific protein markers. This was a key method for differentiating the origin of the tumor, comparing the expression patterns to known markers for cervical adenocarcinoma and other adenocarcinomas.
  • Surgical Intervention: The patient underwent anterior pelvic exenteration, followed by chemotherapy and later a laparoscopic ultralow rectal anterior resection.
  • Literature Review: The authors reviewed existing literature on UrC diagnosis, treatment, and differential diagnosis to contextualize their case.

The novelty lies in the detailed pathological and immunohistochemical analysis that ultimately led to the correct diagnosis of UrAC with cervical invasion, correcting a prior misdiagnosis.

Datasets

Not discussed in the paper. This is a case report, not a study involving large datasets or the introduction of new benchmarks.

Key Insights and Ideas

  • The Diagnostic Mimicry of UrAC: This case powerfully illustrates how UrAC can mimic other cancers, leading to significant diagnostic delays. The cervical invasion in this instance was a major confounding factor.
  • The Indispensable Role of IHC: Immunohistochemistry was the cornerstone in unraveling the true origin of the tumor. The specific panel of markers used helped rule out primary cervical adenocarcinoma and strongly suggested a urachal origin.
  • The Challenge of Early UrC Detection: The paper reinforces that UrC is often diagnosed late, underscoring the need for a high index of suspicion for unusual presentations.
  • Anterior Pelvic Exenteration as a Treatment Option: For patients with local pelvic recurrence of UrAC, anterior pelvic exenteration, despite its radical nature, appears to be a viable surgical option, as demonstrated in this case.

Key Results

  • The patient, initially diagnosed with FIGO stage IIIB cervical adenocarcinoma in 2017, was later found to have urachal adenocarcinoma (UrAC) with cervical and vaginal invasion.
  • Histopathological reassessment and extensive immunohistochemical analysis (including markers like CK7, CEA, CA199, CDX-2, and P16 negativity) were critical in establishing the correct diagnosis of UrAC.
  • The patient underwent anterior pelvic exenteration, followed by chemotherapy for rectal metastasis.
  • The authors report this as the first documented case of UrAC being misdiagnosed as primary cervical cancer.

Limitations and Future Work

  • Rarity of the Case: The extreme rarity of this specific presentation (UrAC with cervical invasion) limits the generalizability of findings.
  • Diagnostic Challenges: The paper highlights the ongoing difficulty in preoperative diagnosis of UrC, emphasizing the need for improved diagnostic tools and strategies.
  • Treatment Efficacy: While anterior pelvic exenteration showed promise in this case for local recurrence, the authors stress that further investigation and prospective data are needed to validate its efficacy as a standard treatment strategy.
  • Molecular Profiling: While IHC was extensively used, the paper briefly mentions the potential role of molecular alterations in UrC and suggests that further research into these could aid diagnosis and treatment.

Summary updated

Abstract

UrC is rare, and preoperative differential diagnosis is difficult. This is the first report of UrC being misdiagnosed as cervical cancer. The presented case highlights the importance of accurate histopathological examination and comprehensive analysis. Anterior pelvic exenteration was also identified as a potentially effective treatment strategy for patients with local pelvic recurrence of UrC, although further investigation is required.
BibTeX
@inproceedings{wang2024urachal,
  author = {Yiran Wang and Maomao Li and Kaixuan Yang and Qingli Li and Ping Wang},
  title = {{Urachal adenocarcinoma with cervical invasion misdiagnosed as primary cervical adenocarcinoma: a case report and literature review}},
  booktitle = {Frontiers in Oncology},
  year = {2024},
  doi = {10.3389/fonc.2024.1410291},
}
Figure